Clinical Trial Update: Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 trial update for intravenous immunoglobulin therapy in small fiber neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Fiber Neuropathy

Drugs mentioned

• Intravenous immunoglobulin therapy (intravenous immunoglobulin)

Snippet

Sponsor: Academisch Ziekenhuis Maastricht | Conditions: Small Fiber Neuropathy | Phase 2 | Status: COMPLETED